7 studies found for:
cholangiocarcinoma | United States, North Carolina
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Active, not recruiting |
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
|
||||
| 2 |
Completed
Has Results |
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma
|
||||
| 3 | Active, not recruiting |
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
|
||||
| 4 | Recruiting |
6,8-Bis(Benzylthio)Octanoic Acid in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery
|
||||
| 5 | Completed |
Biological Therapy in Treating Patients With Metastatic Cancer
|
||||
| 6 | Completed |
Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer
|
||||
| 7 | Completed |
Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
|
† Indicates status has not been verified in more than two years